What patients in the UK typically pay

At London Cartilage Clinic — currently the only UK clinic openly publishing a ChondroFiller injection price — the cost is structured by treatment volume:

• One box: £3,000
• Two boxes: £5,500
• Three boxes: £8,000

These are guide prices, confirmed after clinical assessment, and each tier is all-inclusive. A single price covers the specialist consultation, real-time ultrasound guidance, the ChondroFiller product itself (imported from Germany under prescription), IV antibiotic cover, the injection procedure, and a six-week clinical follow-up appointment.

For most patients with a focal knee cartilage defect, one box is sufficient — making £3,000 the figure most relevant to the majority of enquiries. Larger surface areas or multi-compartment knee involvement may require two or three boxes; the treating clinician confirms the volume needed after reviewing the patient's imaging and clinical findings.

ChondroFiller knee injection is available only through private healthcare in the UK. There is no NHS commissioning pathway, and the treatment is not routinely covered by private medical insurance. Final costs should be verified directly with the clinic, as prices may vary depending on individual clinical circumstances.

What the price includes — and what it does not

The all-inclusive structure means most of what a patient needs on the day — and in the weeks that follow — sits inside a single quoted figure.

Included in the package price:

• Specialist consultation
• Real-time ultrasound guidance and image-guided placement
• The ChondroFiller collagen scaffold product
• IV antibiotic prophylaxis on the day
• The injection procedure itself
• Six-week clinical follow-up appointment

Not included:

• MRI — a current scan is required to confirm the size and location of the cartilage defect before treatment can be planned; patients without recent cross-sectional imaging should budget for this separately
• Physiotherapy — recommended to support recovery following treatment; costs vary by provider and location
• Travel or accommodation

Within the package, the ChondroFiller product is explicitly identified as the largest single cost component. The scaffold is a CE-marked Class III medical device — an acellular collagen matrix manufactured by meidrix biomedicals GmbH in Esslingen, Germany, and imported into the UK under prescription — and its regulatory classification and supply chain both contribute to the total price.

The same tiered structure (£3,000 / £5,500 / £8,000) also applies at this clinic to Arthrosamid and PRF. This reflects a consistent approach to pricing the full specialist pathway — imaging, antibiotic cover, clinical follow-up, and specialist time — across premium regenerative injections. For ChondroFiller specifically, the product accounts for the largest share of that total, which is the practical reason it sits materially above a standard steroid injection (£900) or hyaluronic acid (£1,200).

Why the number of boxes changes the cost

The amount of ChondroFiller needed is determined by the surface area of the cartilage defect being treated. One box covers most focal, single-compartment defects — a discrete area of damage confined to one articular surface, such as the medial femoral condyle or the trochlear groove. Where the affected area is larger, spans more than one load-bearing surface, or involves multiple compartments of the same knee, the volume required increases accordingly.

Several clinical variables feed into that calculation: the two-dimensional extent of the defect, whether damage crosses more than one compartment, and whether more than one area is being addressed in the same appointment. These are not factors a patient can estimate reliably from symptoms. Articular cartilage lacks a direct nerve supply, which means pain intensity and defect size do not map in any consistent way — a large defect may cause fewer symptoms than a small but mechanically awkward one. Current MRI is the basis for the volume assessment; the clinician uses imaging to plan the treatment before the appointment is confirmed, so patients should bring or arrange up-to-date cross-sectional imaging rather than drawing conclusions from symptom severity alone.

How ChondroFiller compares in cost to other knee treatments

Seen alongside the full range of private knee treatments, ChondroFiller injection occupies a distinct position — above standard outpatient injections, well below surgical alternatives, and with a different underlying mechanism from either end of that range.

The cost ladder, based on published London Cartilage Clinic prices, runs as follows:

• Corticosteroid injection: ~£900 — a short-term anti-inflammatory option with a legitimate role in acute flare management and pre-procedure pain control; not a repair pathway
• PRP or hyaluronic acid injection: ~£1,200 — PRP provides biologic support; hyaluronic acid is a viscosupplement that may ease symptoms and reduce friction but does not restore cartilage structure
• ChondroFiller injection (one box): £3,000 — an acellular collagen scaffold placed under ultrasound guidance; the mechanism is matrix-induced chondrogenesis, supporting the body's own repair processes rather than masking symptoms
• Knee cartilage repair surgery: from ~£9,800 — a surgical procedure requiring theatre admission, anaesthetic, and a materially longer recovery trajectory
• Knee replacement: £12,000–£17,000 — an end-stage intervention carrying the full burden of major joint surgery

The step from PRP to ChondroFiller reflects a meaningful difference in mechanism — symptomatic relief versus a resorbable scaffold that recruits the patient's own progenitor cells — as well as the supply cost of a Class III CE medical device imported under prescription. In published knee investigations, patients reported approximately 30-point IKDC improvements over 12 months; the manufacturer presents this as a reported outcome, not a guarantee for any individual. Surgery and joint replacement are not inferior options — they are different pathway stages, appropriate when the clinical picture demands them.

NHS coverage and private medical insurance

Private medical insurance does not routinely cover the ChondroFiller injection pathway. The clinic can provide an itemised invoice for patients who wish to submit an independent claim to their insurer, but this is a courtesy arrangement — reimbursement is not guaranteed and should not be factored into cost planning.

One distinction is worth understanding before contacting an insurer. The surgical variant of the same implant — marketed as Liquid Cartilage™ and delivered arthroscopically — has recognised CCSD billing codes: W3111 (cartilage regeneration with collagen scaffold) and W8500 (arthroscopy). In some cases, Bupa, Aviva, and WPA have granted pre-authorisation for that surgical route, though outcomes vary and written pre-authorisation is always required before proceeding. The outpatient injection pathway described in this article is a different clinical route, and the insurance pathway that exists for the surgical procedure does not automatically extend to it.

Patients considering the injection on a budget should plan for the full package cost as a self-funded outpatient expense, then treat any insurer response as a secondary possibility rather than a reliable offset. A consultant assessment will confirm which pathway — injection or surgical — is most appropriate, and that distinction may in turn affect whether a PMI conversation is worth pursuing.

Getting a cost-confirmed assessment at Lincolnshire Knee

The guide prices set out in this article are published by London Cartilage Clinic, which is part of the same MSK Doctors group as Lincolnshire Knee. Patients based outside London who are considering a ChondroFiller injection assessment can therefore access the same consultant-led pathway — including the same treatment and the same tiered pricing structure — closer to home.

Lincolnshire Knee accepts patients without a GP referral and without the waiting times typical of NHS pathways. The published figures of £3,000, £5,500, and £8,000 are guide costs; the exact price is confirmed only after a clinical assessment and imaging review, because the number of boxes required depends on the size and location of the cartilage defect. An MRI review is part of that assessment process and informs treatment planning before any cost commitment is made.

Clinics are based in Sleaford NG34 and Grantham NG31. To book an assessment, visit lincolnshireknee.co.uk.